drugs controller general of india news
Latest from drugs controller general of india
Karnataka govt asks DCGI to probe Ringer Lactate firm after maternal deaths
According to the Health Department, between November 9 and 11, four maternal deaths were reported at the district hospital in Ballari.
Published on Dec 03, 2024 07:50 PM IST
PTI | | Posted by Pathi Venkata Thadhagath
DCGI asks doctors to advise patients against use of Pholcodine cough syrups
The DCGI has issued an alert on cough and cold remedies containing Pholcodine due to safety concerns triggering severe allergic reactions.
Published on Jul 20, 2023 01:21 PM IST
Test cough syrups meant for exports on priority: DCGI
DCGI on Wednesday directed state drugs regulators and government laboratories to test cough syrup samples meant for exports “on top priority” and issue reports at the earliest.
Updated on May 25, 2023 12:34 AM IST
Rhythma Kaul, New Delhi
Covovax to be available on CoWIN as booster dose soon. Check details
Covovax is likely to be available on the portal in a few days at a price of ₹225 per dose plus applicable GST.
Published on Apr 10, 2023 05:00 PM IST
PTI |
Serum institute seeks to add Covovax on CoWIN portal as booster dose for adults
Last month, COVID-19 Working Group also recommended to the health ministry inclusion of Covovax on the CoWIN portal as a heterologous booster dose for adults.
Published on Apr 03, 2023 08:10 PM IST
PTI |
Gambia deaths: Expert dismisses fears about Indian cough syrups
Gambia alleged that kidney injuries linked to India-made paracetamol syrup caused 66 child deaths in the past three months.
Published on Oct 08, 2022 02:03 PM IST
Nisha Anand | Edited by Poulomi Ghosh
News updates from HT: Akali leader Majithia gets interim protection from arrest
Here are today’s top news, analysis, and opinion. Know all about the latest news and other news updates from Hindustan Times.
Published on Jan 10, 2022 04:57 PM IST
hindustantimes.com, Hindustan Times, New Delhi
Govt to buy one crore doses of Zydus Cadila's needle-free Covid-19 vaccine
ZyCoV-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above. It received emergency use authorisation from the drug regulator on August 20.
Published on Nov 07, 2021 02:29 PM IST
Dr Reddy’s gets DCGI nod to conduct phase 3 Sputnik Light trials
The Drugs Controller General of India (DCGI) has allowed Hyderabad-based Dr Reddy’s Laboratories to conduct phase 3 bridging trials of Sputnik Light, the single dose formulation of the Russia-made Sputnik V Covid-19 vaccine
Updated on Sep 16, 2021 02:57 AM IST
Rhythma Kaul, Hindustan Times, New Delhi
'Need more scientific data to clarify’: Centre on mixing of Covid-19 vaccines
The Drugs Controller General of India in August approved a proposal by the CMC Vellore, Tamil Nadu, to conduct a study to analyse the mixing of one dose each of Covaxin and Covishield doses.
Published on Sep 14, 2021 09:51 PM IST
Written by Sharangee Dutta | Edited by Avik Roy, Hindustan Times, New Delhi
Biological E’s Corbevax may be launched in October: Niti Aayog’s VK Paul
Corbevax, the second jab against the virus being made in the country, is an RBD protein sub-unit vaccine. On Wednesday, the Drug Controller General of India (DGCI) gave permission to Biological E to conduct phase 2/3 clinical trials of Corbevax on children between five-18 years with certain conditions.
Published on Sep 02, 2021 09:43 PM IST
Written by Harshit Sabarwal | Edited by Sohini Goswami, New Delhi
DCGI allows Serum Institute to manufacture Sputnik V vaccine in India
The Pune-based SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, in Russia for developing Sputnik V at its licensed Hadapsar facility.
Published on Jun 04, 2021 09:10 PM IST
hindustantimes.com | Written by Joydeep Bose